200 Boston Ave Ste 3600, Medford, Massachusetts, 02155, United States
Overview
Scion is focused on drug discovery. BioWorld reported the company closed a $17.5 million financing round on July 19, 2002. The article does not disclose the structure or terms of the financing. The report also does not name any participating investors or provide operating metrics. No details on product pipeline, future plans, founding year or location are provided in the article.
